MedTrace Logo

PET Study of the Nicotinic Receptors in Human

NCT00543322 · Status: TERMINATED · Type: OBSERVATIONAL

Last updated 2007-10-12

No results posted yet for this study

Summary

The purpose of this study is to quantify the brain distribution of the nicotinic receptors in human volunteers and their alterations in patients suffering from neurological diseases such as Parkinson and Alzheimer diseases and familial epilepsy. This will be done using Postron Emission Tomography (PET) and a new radiotracer of the nicotinic receptors.

Conditions

  • Healthy
  • Parkinson Disease
  • Alzheimer Disease
  • Epilepsy

Sponsors & Collaborators

  • Commissariat A L'energie Atomique

    lead OTHER_GOV

Principal Investigators

  • MICHEL BOTTLAENDER, MD PhD · CEA

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-07-31
Completion
2006-07-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00543322 on ClinicalTrials.gov